-+ 0.00%
-+ 0.00%
-+ 0.00%

Daxor Secures FDA 510(k) Clearance For Handheld Blood Volume Analyzer

Benzinga·08/07/2025 11:57:08
Listen to the news

Management Expects High Demand Driven by Speed, Simplicity, and Clinical Precision

Oak Ridge, TN, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology, today announces FDA 510(k) clearance (K251087) for its patent-pending next-generation rapid, compact, hand-held, lab-based Blood Volume Analyzer (BVA). The new Daxor BVA™ device quantifies a patient's blood volume against patient-specific norms, enabling precise fluid management across a broad spectrum of clinical conditions affecting millions of patients each year.